Zura Bio Limited (ZURA)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Zura Bio Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Zura Bio Limited (ZURA) has returned 13.55% so far this year and 361.24% over the past 12 months.

Based on dividend-adjusted daily data since Sep 3, 2021, ZURA's average daily return is +0.26%, while the average monthly return is +2.33%. At this rate, your investment would double in approximately 2.5 years.

Historically, 58% of months were positive and 42% were negative. The best month was Sep 2025 with a return of +112.3%, while the worst month was Apr 2023 at -54.4%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 5 months.

On a daily basis, ZURA closed higher 37% of trading days. The best single day was Mar 22, 2023 with a return of +314.4%, while the worst single day was Mar 27, 2023 at -42.8%.

Zura Bio Limited has an annualized alpha of 86.90%, beta of 0.33, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since September 07, 2021.

• This stock tended to rise when S&P 500 Index fell (downside capture of -33.39%), but participation in market rallies was also limited (-40.16%) — a profile typical of counter-cyclical assets.
• Beta of 0.33 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

ZURA ranks 96 for risk / return — in the top 96% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Zura Bio Limited (ZURA) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Zura Bio Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Zura Bio Limited was 97.00%, occurring on May 28, 2025. The portfolio has not yet recovered.

The current Zura Bio Limited drawdown is 82.08%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Zura Bio Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Zura Bio Limited is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.